The ankle's ability to regenerate cartilage uses the same mechanisms that enable some animals to grow new limbs, and it could ...

Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.

MONDAY, June 16, 2025 (HealthDay News) -- Transfibular total ankle arthroplasty (TAA) seems effective and durable for end-stage ankle arthritis, according to a study published online April 29 in ...

Stryker SYK recently received FDA clearance for its InCompass Total Ankle System, marking a pivotal expansion in the company's Foot & Ankle portfolio. Designed to address end-stage ankle arthritis ...

Stryker, the medical technologies provider in Portage (near Kalamazoo), has received U.S. Food and Drug Administration 510(k) ...

Many people expect a little foot pain as they get older. But if your foot or ankle hurts for a long time and rest, ice, medicine and keeping it raised ...

The Executive Committee of the International Ankle Consortium presents this 2016 position paper with recommendations for information implementation and continued research based on the paradigm that ...

Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE ...

AS summer gets into full swing, there’s no better time to focus on your health. Whether you’re embracing the sunshine (and ...

This study evaluates the outcomes of total ankle arthroplasty in both ankles with anteriorly translated talus and those with non-translated talus. How do they compare?

Stryker received FDA 510 (k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.